These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7157360)

  • 1. [Pharmacokinetics of arsenic trioxide in the mouse].
    Brunet C; Luyckx M; Cazin M
    Toxicol Eur Res; 1982 Jul; 4(4):175-9. PubMed ID: 7157360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Topographic distribution of arsenous anhydride in pregnant mice using macroscopic autoradiography].
    Brunet C; Luyckx M; Cazin M
    Toxicol Eur Res; 1983 Mar; 5(2):55-61. PubMed ID: 6612724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and excretion of orally administrated arsenic trioxide in the hamster.
    Yamauchi H; Yamamura Y
    Toxicology; 1985 Feb; 34(2):113-21. PubMed ID: 3969684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of arsenic trioxide and calcium arsenate retention in the rat lung after intratracheal instillation.
    Inamasu T; Hisanaga A; Ishinishi N
    Toxicol Lett; 1982 Jun; 12(1):1-5. PubMed ID: 7112598
    [No Abstract]   [Full Text] [Related]  

  • 5. Arsenic contamination: metabolic effects and localization in rats.
    Fuentes N; Zambrano F; Rosenmann M
    Comp Biochem Physiol C Comp Pharmacol; 1981; 70(2):269-72. PubMed ID: 6118228
    [No Abstract]   [Full Text] [Related]  

  • 6. Arsenic metabolites in hair, blood and urine in workers exposed to arsenic trioxide.
    Yamamura Y; Yamauchi H
    Ind Health; 1980; 18(4):203-10. PubMed ID: 7251401
    [No Abstract]   [Full Text] [Related]  

  • 7. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
    Rousselot P; Labaume S; Marolleau JP; Larghero J; Noguera MH; Brouet JC; Fermand JP
    Cancer Res; 1999 Mar; 59(5):1041-8. PubMed ID: 10070961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment.
    Sweeney CJ; Takimoto C; Wood L; Porter JM; Tracewell WG; Darwish M; D'Andrea DM; Remick SC
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):345-56. PubMed ID: 19911123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism of arsenic in humans acutely intoxicated by As2O3. Its significance for the duration of BAL therapy.
    Mahieu P; Buchet JP; Roels HA; Lauwerys R
    Clin Toxicol; 1981 Sep; 18(9):1067-75. PubMed ID: 7318390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolism of arsenic (15). Influence of arsenic antidotes on intestinal absorption of arsenic trioxide].
    Tsutsumi S; Nozaki S
    Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):545-51. PubMed ID: 1104420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Nrf2 Signaling Pathway Involving KLF9 Plays a Critical Role in Allicin Resisting Against Arsenic Trioxide-Induced Hepatotoxicity in Rats.
    Yang D; Lv Z; Zhang H; Liu B; Jiang H; Tan X; Lu J; Baiyun R; Zhang Z
    Biol Trace Elem Res; 2017 Mar; 176(1):192-200. PubMed ID: 27561292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of arsenic retention by resveratrol in lung of arsenic trioxide-exposed rats.
    Zhang W; Yao C; Ge M; Xue J; Ma D; Liu Y; Liu J; Zhang Z
    Environ Toxicol Pharmacol; 2013 Jul; 36(1):35-9. PubMed ID: 23545367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arsenic trioxide inhibition of the thiophosphamide induction of mutations in mouse germ and somatic cells].
    Pashin IuV; Kozachenko VI; Toroptsev SN
    Genetika; 1984 Feb; 20(2):365-6. PubMed ID: 6423448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice.
    Xie Y; Trouba KJ; Liu J; Waalkes MP; Germolec DR
    Environ Health Perspect; 2004 Aug; 112(12):1255-63. PubMed ID: 15345372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of haemodialysis and 2,3 propanesulphonate (DMPS) to manage acute oral poisoning by lethal dose of arsenic trioxide.
    Kruszewska S; Wiese M; Kołaciński Z; Mielczarska J
    Int J Occup Med Environ Health; 1996; 9(2):111-5. PubMed ID: 8803325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
    Modak S; Zanzonico P; Carrasquillo JA; Kushner BH; Kramer K; Cheung NK; Larson SM; Pandit-Taskar N
    J Nucl Med; 2016 Feb; 57(2):231-7. PubMed ID: 26742708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: tissue accumulation and the reversibility after washout are tissue-selective.
    Lin CJ; Wu MH; Hsueh YM; Sun SS; Cheng AL
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):170-8. PubMed ID: 15322825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental studies on arsenic absorption routes in rats.
    Dutkiewicz T
    Environ Health Perspect; 1977 Aug; 19():173-6. PubMed ID: 908295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of administration styles of arsenic trioxide on intracellular arsenic concentration, cell differentiation and apoptosis.
    Zhou J; Meng R; Sui X; Meng L; Jia J; Yang B
    Haematologica; 2005 Sep; 90(9):1277-9. PubMed ID: 16154855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns.
    Golub MS; Macintosh MS; Baumrind N
    J Toxicol Environ Health B Crit Rev; 1998; 1(3):199-241. PubMed ID: 9644328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.